Second–Line Biologic Therapy Following Tumor Necrosis Factor Antagonist Failure: A Real–World Propensity Score–Weighted Analysis
- Resource Type
- Article
- Source
- In
Clinical Gastroenterology and Hepatology September 2023 21(10):2629-2638 - Subject
- Language
- ISSN
- 1542-3565